[Efficacy of selective bronchial occlusion in the treatment of intractable pneumothorax].

医学 气胸 治愈率 耐火材料(行星科学) 外科 病历 内科学 天体生物学 物理
作者
Lisong Lin,X Y Chen,Hailin Zhang,Y F Chen,Y X Zhang,Yiming Zeng
出处
期刊:PubMed 卷期号:102 (44): 3501-3504
标识
DOI:10.3760/cma.j.cn112137-20220708-01510
摘要

Objective: To analyze the effect of selective bronchial occlusion (SBO) in the treatment of intractable pneumothorax. Methods: A total of 86 patients with refractory pneumothorax treated with SBO in the Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Fujian Medical University from January 1, 2019 to December 31, 2021 were included in this study. The basic information, diagnosis and treatment of the patients were collected and analyzed based on their inpatient records. Results: The age of the subjects was (62±11) years old, and 83 cases (96.5%) were male. The first time SBO cure rate was 30.2% (26/86). The effective rate of the first time SBO treatment was 38.4% (33/86), and the final cure rate of SBO was 59.3% (51/86). The total cure rate of SBO combined with other therapies was 73.3% (63/86). The median time [M (Q1, Q3)] from the first plugging to the complete cessation of air leakage in SBO cured patients was 6.5 (3, 7) days, which was shorter than that in the final extubation patients after SBO [11 (7, 19) days] (H=30.24, P<0.001). The median [M (Q1, Q3)] length of hospital stay of the first SBO cured patients was 19 (14, 25) days, which was shorter than that of all patients [28 (19, 37) days] (H=12.89, P=0.002). The median [M (Q1, Q3)] hospitalization expenses of patients with first SBO cure, effective SBO treatment and ineffective SBO treatment were 23 187 (18 906, 27 798), 41 580 (29 388, 50 762) and 38 462 (27 542, 51 720) yuan, respectively, and the difference was statistically significant (H=18.58, P<0.001). The incidence of complications after SBO was 7.59% (11/145). Conclusion: SBO has good efficacy and relative high safety in the treatment of intractable pneumothorax.目的: 分析选择性支气管封堵术(SBO)对难治性气胸的治疗效果。 方法: 将2019年1月1日至2021年12月31日福建医科大学附属第二医院呼吸与危重症医学科收治的86例接受SBO治疗的难治性气胸患者纳入研究。基于患者的住院病历收集并分析患者的基本情况和诊治情况。 结果: 研究对象年龄为(62±11)岁,其中男性83例(96.5%)。首次SBO治愈率为30.2%(26/86);首次SBO治疗有效率为38.4%(33/86),SBO最终治愈率为59.3%(51/86);SBO联合其他方法治疗的总治愈率为73.3%(63/86)。SBO治愈患者由首次封堵至完全停止漏气时间的M(Q1,Q3)为6.5(3,7)d,短于SBO术后最终拔管患者[11(7,19)d](H=30.24,P<0.001)。首次SBO治愈患者住院天数的M(Q1,Q3)为19(14,25)d,短于全部患者[28(19,37)d](H=12.89,P=0.002)。首次SBO治愈、SBO治疗有效和无效患者住院费用的M(Q1,Q3)分别为23 187(18 906,27 798)、41 580(29 388,50 762)和38 462(27 542,51 720)元,差异具有统计学意义(H=18.58,P<0.001)。SBO术后并发症发生率为7.59%(11/145)。 结论: SBO对难治性气胸具有良好的疗效且安全性较高。.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
穆羊青发布了新的文献求助10
1秒前
淑文发布了新的文献求助10
2秒前
单薄的夜南应助嘻哈采纳,获得10
2秒前
丘比特应助嘻哈采纳,获得10
2秒前
3秒前
酷酷的涵蕾完成签到 ,获得积分10
3秒前
redking发布了新的文献求助10
3秒前
5秒前
6秒前
7秒前
7秒前
HuiJN完成签到 ,获得积分10
7秒前
锤子完成签到,获得积分10
8秒前
在水一方应助lizibelle采纳,获得10
9秒前
hoyden完成签到,获得积分10
9秒前
Stardust发布了新的文献求助10
10秒前
12秒前
momo发布了新的文献求助10
13秒前
13秒前
乐乐应助Mo采纳,获得10
14秒前
14秒前
Liufgui应助Z6kjoA采纳,获得20
14秒前
爆米花应助科研通管家采纳,获得10
16秒前
NexusExplorer应助科研通管家采纳,获得10
16秒前
cangy发布了新的文献求助10
16秒前
英姑应助科研通管家采纳,获得10
16秒前
地表飞猪应助科研通管家采纳,获得10
16秒前
桐桐应助科研通管家采纳,获得10
16秒前
17秒前
Akim应助科研通管家采纳,获得10
17秒前
Orange应助科研通管家采纳,获得10
17秒前
地表飞猪应助科研通管家采纳,获得10
17秒前
科研通AI2S应助科研通管家采纳,获得10
17秒前
酷波er应助科研通管家采纳,获得10
17秒前
地表飞猪应助科研通管家采纳,获得10
17秒前
17秒前
YamDaamCaa应助科研通管家采纳,获得30
17秒前
luo关闭了luo文献求助
18秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989334
求助须知:如何正确求助?哪些是违规求助? 3531428
关于积分的说明 11253936
捐赠科研通 3270119
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173